Endotracheal IntubationNCT06089187
Comparing Endotracheal Tube Cuff Pressure in Laparoscopic Abdominal Surgery: Saline vs. Air Inflation
A study testing Endotracheal intubation using an endotracheal tube with cuff inflated with air and Endotracheal intubation using an endotracheal tube with cuff inflated with saline in people with Endotracheal Intubation, run by Cukurova University at 1 site in Turkey (Türkiye).
Trial summary
In this study, the investigators aim to compare the incidence of cuff pressure increase between endotracheal tubes inflated with air or saline during elective laparoscopic abdominal surgery under general anesthesia with N2O. Read more about this study
- Who is it for?
- Ages 18 to 65 years
- Conditions the study is for
- Endotracheal Intubation
- What is being tested?
- Endotracheal intubation using an endotracheal tube with cuff inflated with air and Endotracheal intubation using an endotracheal tube with cuff inflated with saline
- Type of treatment
- Surgery or procedure
- Could I receive a placebo?
- Yes, some participants may receive a placebo
- How many people
- 60 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- 27 Sep 2023to 12 Dec 2023
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 65 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- aged 18-65,
- American Society of Anesthesiologists physical status 1 or 2
- Expected surgery time of 30-120 minutes,
- Scheduled for elective laparoscopic abdominal surgery
Who cannot join
- neuropsychiatric disease
- muscle disease
- serious cardiovascular and respiratory system disease
- upper respiratory tract infection in the last 14 days
- morbid obesity
- alcohol or substance addiction
Show all 10Show fewer
- history of bronchospasm
- expectation of difficult intubation
- history of tracheostomy
- history of laryngeal disease or surgery.
Trial locations and contacts
1 site in 1 country.
Turkey (Türkiye)1 site
Department of Anesthesiology, Cukurova University Faculty of Medicine
Adana, 01130
About this study
Official title: A Comparative Analysis of Elevated Endotracheal Tube Cuff Pressure Incidence in Elective Laparoscopic Abdominal Surgery: Saline vs. Air Inflation
In this study, the investigators aim to compare the incidence of cuff pressure increase between endotracheal tubes inflated with air or saline during elective laparoscopic abdominal surgery under general anesthesia with N2O. This prospective observational study will be conducted on 60 patients aged 18-65 with ASA physical status I-II undergoing elective laparoscopic abdominal surgery under general anesthesia. Patients are randomly assigned to two groups: one group has tubes inflated with air (Group H, n=30), while the other group has tubes inflated with saline (Group S, n=30). The cuff pressure is continuously monitored using a pressure transducer attached to the cuff via a three-way tap. Anesthesia maintenance is achieved with sevoflurane and oxygen/N2O (%40/%60) in both groups. The intervention is performed whenever the cuff pressure exceeds 20 mmHg for >30 seconds during the CO2 insufflation of the abdomen, and the pressure is reduced. The number of interventions is recorded as the primary outcome of the study. The cuff pressure is measured before and after insufflation and after the patients are placed in Trendelenburg and reverse Trendelenburg positions.
Read the detailed description
The study is designed as prospective and observational research, which takes place at the Balcalı Hospital of Çukurova University between July 2023 and October 2023. After obtaining written informed consent from the participants and approval from the Çukurova University Clinical Research Ethics Committee (Date: 13.07.2023 and Decision no: 186/10), a total of 60 patients, aged between 18-65, with ASA 1-2 risk category, and expected surgical duration of 30-120 minutes, are included in the study for elective laparoscopic abdominal surgery. The exclusion criteria include neuropsychiatric diseases, muscle diseases, significant cardiovascular and respiratory system diseases, upper respiratory tract infection within the past 14 days, morbid obesity, alcohol or substance dependence, history of bronchospasm, expected difficult intubation, history of tracheostomy, and laryngeal diseases or surgery. After informing the patients about the procedure and obtaining written consent, intravenous (IV) access is established in the preoperative preparation room after an 8-hour fasting period. No premedication is administered. Once the patients are transferred to the operating room, standard anesthesia monitoring including electrocardiography (ECG), non-invasive blood pressure, peripheral oxygen saturation (SpO2), and end-tidal CO2 (EtCO2) are applied. Following 3 minutes of preoxygenation with 100% oxygen, anesthesia induction is performed with a 2 mg/kg IV propofol. TOF (train-of-four) monitor calibration is performed to assess the level of muscle relaxation. Subsequently, 0.6 mg/kg of rocuronium IV is administered for neuromuscular blockade. Fentanyl 1 mcg/kg IV is given during anesthesia induction. Endotracheal intubation (ETI) is performed using a high-volume, low-pressure cuffed endotracheal tube (ETT) with an internal diameter of 7-7.5 mm for female patients and 8-8.5 mm for male patients, once the TOF measurement reaches 0. The intubation procedure is carried out by an experienced anesthesiologist using a Macintosh laryngoscope. According to the randomization table created with a computer program, patients who are randomly selected after endotracheal intubation have the APL valve of the anesthesia machine adjusted to a pressure of 20 cmH20, ensuring that there is no air leakage sound from the patient's mouth during ventilation. The ETT cuffs of patients in Group H are inflated with air, while those in Group S are inflated with saline. The cuff pressure is continuously monitored using a pressure transducer connected to the cuff balloon through a three-way stopcock. The transducer set is filled with saline to ensure no air is present. It is connected to a three-way stopcock at the desired measurement point level. All connections are taped to prevent disconnection and leaks, and a "For Respiratory Use Only" label is affixed to enhance patient safety. The pressure calibration on the patient monitor is adjusted according to the sternal notch level of the patient, and the cuff pressure value is measured in mmHg. After ETT placement, ventilation of the patient is set as volume-controlled ventilation with a tidal volume of 6-8 ml/kg, frequency of 10-12/min, and EtCO2 of 35-45 mmHg. An esophageal temperature measurement probe is placed to monitor body temperature. Maintenance of anesthesia for all patients is achieved using a gas mixture of sevoflurane and oxygen/nitrous oxide (40%/60%). When the TOF value is 2 during the maintenance of muscle relaxation, rocuronium 0.15 mg/kg is administered intravenously. Nasogastric tubes are placed in all patients. 45 minutes before the completion of the surgery, tramadol 2 mg/kg IV and paracetamol 1 g IV are administered to provide postoperative analgesia. In cases where the intracuff pressure exceeds 20 mmHg for more than 30 seconds during CO2 insufflation, intervention is performed using a three-way stopcock and syringe to reduce the pressure to 18 mmHg, and the number of interventions is recorded. The highest intracuff pressure, ventilator peak pressure, plateau pressure, and PEEP are recorded every 15 minutes during the first minute after CO2 insufflation. In cases where the intracuff pressure exceeds 20 mmHg for more than 30 seconds during this period, intervention is performed to reduce the pressure to 18 mmHg using a three-way stopcock and syringe. The number of interventions is recorded. Additionally, the intracuff pressures before and after the patients are placed in the reverse Trendelenburg and Trendelenburg positions are recorded. At the end of the surgery, 0.04 mg/kg neostigmine IV and 0.01 mg/kg atropine IV are administered to reverse the effects of muscle relaxation. The patients are extubated when they respond adequately to verbal stimuli and the train-of-four (TOF) value is 90% or above. Once sufficient muscle strength and airway safety are ensured, the patients are transferred from the operating room to the postoperative recovery unit.
In our pilot study, we observed that the total number of interventions 30 minutes after insufflation differed significantly between the saline group (mean = 2.31) and the air group (mean = 4.01), with a standard deviation of 1.68. To ensure a 95% power and a significance level of 0.05%, we determined that a sample size of 27 patients per group (total of 57 patients) was necessary. To account for potential data loss, we included 60 patients in the study.
- Conditions
- Endotracheal Intubation
- Being tested
- Endotracheal intubation using an endotracheal tube with cuff inflated with air, Endotracheal intubation using an endotracheal tube with cuff inflated with saline
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Endotracheal intubation using an endotracheal tube with cuff inflated with airProcedure or surgery
After endotracheal intubation, the endotracheal tube cuff is inflated with air
Endotracheal intubation using an endotracheal tube with cuff inflated with salineProcedure or surgery
After endotracheal intubation, the endotracheal tube cuff is inflated with saline
| Study group | Role | What they receive |
|---|---|---|
| Saline Group | Active comparator | Anesthesia machine's APL valve will be adjusted to a pressure of 20 cmH20, and during ventilation with a balloon, the endotracheal tube cuffs will be inflated with saline in such a way that there will be no leakage sound from the patient's mouth. Receives: Procedure: Endotracheal intubation using an endotracheal tube with cuff inflated with saline |
| Air Group | Placebo comparator | Anesthesia machine's APL valve will be adjusted to a pressure of 20 cmH20, and during ventilation with a balloon, the endotracheal tube cuffs will be inflated with air in such a way that there will be no leakage sound from the patient's mouth. Receives: Procedure: Endotracheal intubation using an endotracheal tube with cuff inflated with air |
What is being measured
The primary outcome is the main question the study is designed to answer.
The number of intervention
The number of interventions required to correct intracuff pressure
Measured: 15 minutes
Secondary outcomes (1)
Peak Airway pressure
Peak airway pressure during the intraoperative period is measured in cmH2O.
Measured: 15 minutes
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted18 Oct 2023
- Study start27 Sep 2023
- Primary completion12 Dec 2023
- Study completion12 Dec 2023
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for Endotracheal IntubationStudies of the same condition, open and under way.
- More trials run by Cukurova UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- Prospective randomized controlled study
- Masking
- Single blind
- Who is masked
- Participant
- Enrolment
- 60 participants (actual)
Sponsor and investigators
- Lead sponsor
- Cukurova University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Ersel GULEC, Cukurova University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06089187
- Sponsor's protocol ID
- ETTSVA
- Status last verified
- Dec 2023
- First submitted
- 26 Sep 2023
- Last updated
- 13 Dec 2023
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Publications
Armstrong J, Jenner P, Poulose S, Moppett IK. The effect of saline versus air for cuff inflation on the incidence of high intra-cuff pressure in paediatric MicroCuff(R) tracheal tubes: a randomised controlled trial. Anaesthesia. 2021 Nov;76(11):1504-1510. doi: 10.1111/anae.15493. Epub 2021 Apr 23.
PubMed 33891328
Study at a glance
From the registry record, last updated by the sponsor on 13 Dec 2023. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- A Comparative Analysis of Elevated Endotracheal Tube Cuff Pressure Incidence in Elective Laparoscopic Abdominal Surgery: Saline vs. Air Inflation
- ClinicalTrials.gov ID
- NCT06089187
- Acronym / sponsor ID
- ETTSVA
- Conditions
- Endotracheal Intubation
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 60 participants (actual)
- Lead sponsor
- Cukurova UniversityUniversity, hospital or other
- Study start
- 27 Sep 2023 (actual)
- Primary completion
- 12 Dec 2023 (actual)
- Study completion
- 12 Dec 2023 (actual)
- First posted
- 18 Oct 2023 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
In this study, the investigators aim to compare the incidence of cuff pressure increase between endotracheal tubes inflated with air or saline during elective laparoscopic abdominal surgery under general anesthesia with N2O. This prospective observational study will be conducted on 60 patients aged 18-65 with ASA physical status I-II undergoing elective laparoscopic abdominal surgery under general anesthesia. Patients are randomly assigned to two groups: one group has tubes inflated with air (Group H, n=30), while the other group has tubes inflated with saline (Group S, n=30). The cuff pressure is continuously monitored using a pressure transducer attached to the cuff via a three-way tap. Anesthesia maintenance is achieved with sevoflurane and oxygen/N2O (%40/%60) in both groups. The intervention is performed whenever the cuff pressure exceeds 20 mmHg for >30 seconds during the CO2 insufflation of the abdomen, and the pressure is reduced. The number of interventions is recorded as the primary outcome of the study. The cuff pressure is measured before and after insufflation and after the patients are placed in Trendelenburg and reverse Trendelenburg positions.
Detailed description
The study is designed as prospective and observational research, which takes place at the Balcalı Hospital of Çukurova University between July 2023 and October 2023. After obtaining written informed consent from the participants and approval from the Çukurova University Clinical Research Ethics Committee (Date: 13.07.2023 and Decision no: 186/10), a total of 60 patients, aged between 18-65, with ASA 1-2 risk category, and expected surgical duration of 30-120 minutes, are included in the study for elective laparoscopic abdominal surgery. The exclusion criteria include neuropsychiatric diseases, muscle diseases, significant cardiovascular and respiratory system diseases, upper respiratory tract infection within the past 14 days, morbid obesity, alcohol or substance dependence, history of bronchospasm, expected difficult intubation, history of tracheostomy, and laryngeal diseases or surgery. After informing the patients about the procedure and obtaining written consent, intravenous (IV) access is established in the preoperative preparation room after an 8-hour fasting period. No premedication is administered. Once the patients are transferred to the operating room, standard anesthesia monitoring including electrocardiography (ECG), non-invasive blood pressure, peripheral oxygen saturation (SpO2), and end-tidal CO2 (EtCO2) are applied. Following 3 minutes of preoxygenation with 100% oxygen, anesthesia induction is performed with a 2 mg/kg IV propofol. TOF (train-of-four) monitor calibration is performed to assess the level of muscle relaxation. Subsequently, 0.6 mg/kg of rocuronium IV is administered for neuromuscular blockade. Fentanyl 1 mcg/kg IV is given during anesthesia induction. Endotracheal intubation (ETI) is performed using a high-volume, low-pressure cuffed endotracheal tube (ETT) with an internal diameter of 7-7.5 mm for female patients and 8-8.5 mm for male patients, once the TOF measurement reaches 0. The intubation procedure is carried out by an experienced anesthesiologist using a Macintosh laryngoscope. According to the randomization table created with a computer program, patients who are randomly selected after endotracheal intubation have the APL valve of the anesthesia machine adjusted to a pressure of 20 cmH20, ensuring that there is no air leakage sound from the patient's mouth during ventilation. The ETT cuffs of patients in Group H are inflated with air, while those in Group S are inflated with saline. The cuff pressure is continuously monitored using a pressure transducer connected to the cuff balloon through a three-way stopcock. The transducer set is filled with saline to ensure no air is present. It is connected to a three-way stopcock at the desired measurement point level. All connections are taped to prevent disconnection and leaks, and a "For Respiratory Use Only" label is affixed to enhance patient safety. The pressure calibration on the patient monitor is adjusted according to the sternal notch level of the patient, and the cuff pressure value is measured in mmHg. After ETT placement, ventilation of the patient is set as volume-controlled ventilation with a tidal volume of 6-8 ml/kg, frequency of 10-12/min, and EtCO2 of 35-45 mmHg. An esophageal temperature measurement probe is placed to monitor body temperature. Maintenance of anesthesia for all patients is achieved using a gas mixture of sevoflurane and oxygen/nitrous oxide (40%/60%). When the TOF value is 2 during the maintenance of muscle relaxation, rocuronium 0.15 mg/kg is administered intravenously. Nasogastric tubes are placed in all patients. 45 minutes before the completion of the surgery, tramadol 2 mg/kg IV and paracetamol 1 g IV are administered to provide postoperative analgesia. In cases where the intracuff pressure exceeds 20 mmHg for more than 30 seconds during CO2 insufflation, intervention is performed using a three-way stopcock and syringe to reduce the pressure to 18 mmHg, and the number of interventions is recorded. The highest intracuff pressure, ventilator peak pressure, plateau pressure, and PEEP are recorded every 15 minutes during the first minute after CO2 insufflation. In cases where the intracuff pressure exceeds 20 mmHg for more than 30 seconds during this period, intervention is performed to reduce the pressure to 18 mmHg using a three-way stopcock and syringe. The number of interventions is recorded. Additionally, the intracuff pressures before and after the patients are placed in the reverse Trendelenburg and Trendelenburg positions are recorded. At the end of the surgery, 0.04 mg/kg neostigmine IV and 0.01 mg/kg atropine IV are administered to reverse the effects of muscle relaxation. The patients are extubated when they respond adequately to verbal stimuli and the train-of-four (TOF) value is 90% or above. Once sufficient muscle strength and airway safety are ensured, the patients are transferred from the operating room to the postoperative recovery unit.
In our pilot study, we observed that the total number of interventions 30 minutes after insufflation differed significantly between the saline group (mean = 2.31) and the air group (mean = 4.01), with a standard deviation of 1.68. To ensure a 95% power and a significance level of 0.05%, we determined that a sample size of 27 patients per group (total of 57 patients) was necessary. To account for potential data loss, we included 60 patients in the study.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (participant)
- Number of arms
- 2
- Model description
- Prospective randomized controlled study
| Arm | Type | Receives |
|---|---|---|
| Saline Group | Active comparator | Procedure: Endotracheal intubation using an endotracheal tube with cuff inflated with salineAnesthesia machine's APL valve will be adjusted to a pressure of 20 cmH20, and during ventilation with a balloon, the endotracheal tube cuffs will be inflated with saline in such a way that there will be no leakage sound from the patient's mouth. |
| Air Group | Placebo comparator | Procedure: Endotracheal intubation using an endotracheal tube with cuff inflated with airAnesthesia machine's APL valve will be adjusted to a pressure of 20 cmH20, and during ventilation with a balloon, the endotracheal tube cuffs will be inflated with air in such a way that there will be no leakage sound from the patient's mouth. |
Who may qualify
- Ages
- 18 to 65 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (4 listed)
- aged 18-65,
- American Society of Anesthesiologists physical status 1 or 2
- Expected surgery time of 30-120 minutes,
- Scheduled for elective laparoscopic abdominal surgery
Key exclusion criteria (10 listed)
- neuropsychiatric disease
- muscle disease
- serious cardiovascular and respiratory system disease
- upper respiratory tract infection in the last 14 days
- morbid obesity
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Endotracheal intubation using an endotracheal tube with cuff inflated with airAfter endotracheal intubation, the endotracheal tube cuff is inflated with air | Procedure or surgery | Air Group |
| Endotracheal intubation using an endotracheal tube with cuff inflated with salineAfter endotracheal intubation, the endotracheal tube cuff is inflated with saline | Procedure or surgery | Saline Group |
Primary outcome
The number of intervention
Time frame: 15 minutes
The number of interventions required to correct intracuff pressure
1 secondary outcome
Peak Airway pressure
Time frame: 15 minutes
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 13 Dec 2023.
- Background: PubMed 33891328Armstrong J, Jenner P, Poulose S, Moppett IK. The effect of saline versus air for cuff inflation on the incidence of high intra-cuff pressure in paediatric MicroCuff(R) tracheal tubes: a randomised controlled trial. Anaesthesia. 2021 Nov;76(11):1504-1510. doi: 10.1111/anae.15493. Epub 2021 Apr 23.
- Individual participant dataSharing planned: No
Related trials for Endotracheal Intubation
Not yet recruitingObservational study
AI-assisted Tracheal Intubation in Children
Intubation
Not yet recruiting
AI Smart Glasses Feedback for Intubation Training in Medical Students
Intubation, Intratracheal, Medical Education
Recruiting
Development and Preliminary Validation of Intelligent Video Laryngoscope for Emergency Use
Critically Ill Patients Requiring Mechanical Ventilation
Recruiting
Effect of a Brief Educational Intervention on Endotracheal Tube Cuff Pressure
Intubation, Endotracheal Tube Cuff Pressure
Recruiting
Hyperangulated vs Standard Videolaryngoscopy vs Direct Laryngoscopy for Double-Lumen Endobronchial Tube Intubation
Endobronchial Intubation, Double Lumen Tube Intubation
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Endotracheal intubation using an endotracheal tube with cuff inflated with air and Endotracheal intubation using an endotracheal tube with cuff inflated with saline in people with Endotracheal Intubation, run by Cukurova University at 1 site in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 10 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 13 Dec 2023. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
The number of intervention (time frame: 15 minutes). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT06089187, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Dec 2023.